Vagus nerve stimulation therapy is a safe treatment option for drug-resistant epilepsy over long-term follow-up, but the treatment does have risks, according to a recent study.
Identification of PTSD as a Parkinson’s Disease Risk Factor Could Allow Targeting of Preventive Treatment
VA researchers investigating risk factors for Parkinson’s disease (PD) have identified a strong link between the progressive brain disease and post-traumatic stress disorder (PTSD).
Probability of Unique Symptom Combinations in Mental Health Disorders
Using common diagnostic criteria might have limited generalizability to the large group of individuals with a low-probability symptom combination, according to a new study.
How Anxiety Disorder Can Exist Without ‘Excessive Worry’
Should “excessive worry” be a requirement for a diagnosis of generalized anxiety disorder?
Psychotherapy Beneficial When Veterans With PTSD Have a SUD
Is it beneficial for VA to provide evidence-based psychotherapy (EBP) to veterans with post-traumatic stress disorder and co-occurring substance use disorder?
Higher Rates of Early Menopause Reported in Women Veterans of the Persian Gulf War
Female military personnel from the Persian Gulf War with probable post-traumatic stress disorder (PTSD) are nearly twice as likely to experience early menopause and related health consequences, according to study results presented at the 2024 Annual Meeting of The Menopause Society in Chicago in September.
Costs of Diabetic Kidney Disease Called ‘Profound’ in the United States
Diabetic kidney disease (DKD) affects about one-third of Type 2 diabetes patients, affecting quality of life and causing significant economic burdens on the healthcare system.
Some Disparities Continue in Veterans Newly Diagnosed With T2D
Racial/ethnic disparities in glycemic control among non-Hispanic Black (NHB) and non-Hispanic white (NHW) veterans with Type 2 diabetes (T2D) have persisted, especially with very poor glycemic control, according to a new study.
Changes in the Use of Incretin-Based Therapies for T2D at the VHA
Incretin-based therapies for the management of Type 2 diabetes (T2D) have become a well-established class of drugs within the VHA, according to a new study.
More Education About Antibiotic Benefits/Risks Can Help Curb Unnecessary Usage
Lack of knowledge of the potential risks of antibiotic use was associated with increased expectations of being prescribed one, according to a new study, which said the lack of awareness is especially great among patients going to public health clinics.
‘Simply the Right Thing to Do’: Behind the VA’s Victory Against HCV in Veterans
In the early 2000s, the VA recognized it had a serious problem. Recent research indicated that veterans were three times more likely to be infected with hepatitis C virus (HCV) than the general population, and Vietnam veterans—the largest cohort in care—bore the brunt of those infections.
Stimulating a Target Brain Circuit Holds Promise for Treating PTSD
Scientists studying post-traumatic stress disorder (PTSD) have been puzzled by several mysteries surrounding the condition, such as why military personnel with severe brain injuries are less likely to develop PTSD compared to those without any brain injury or why a neurostimulation therapy that has proven helpful for other mental health disorders actually worsened PTSD in some studies.
Treatment of Small Cell Lung Cancer: Emerging Therapies after Decades of Stagnation
Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer, characterized by rapid growth and early metastasis.
Veterans Face Unique Risks for Small Cell Lung Cancer, Prompting Advances in VA Treatment
Lung cancer remains the leading cause of cancer death in the U.S. and among veterans, who face an increased risk of developing the malignancy.
Military Exposures and Small Cell Lung Cancer in Veterans
Military service often places individuals in environments where they may be exposed to hazardous substances with potential for long-term consequences.
Lung Cancer Survival Rates in Federal Medicine Compare Well to Community
Survival rates appear to be somewhat better for veterans and military healthcare beneficiaries diagnosed with small cell lung cancer (SCLC) but are not as improved as with non-small cell lung cancer (SCLC), according to recent studies.
As Small Cell Lung Cancer Rates Drop, Understanding of Disease Increases
“The more things change, the more they stay the same” could be a tagline for small cell lung cancer (SCLC). In recent decades, the epidemiology of SCLC has shifted substantially, as have the understanding of the disease, screening options and the treatments available. The malignancy, however, remains both challenging and highly lethal.
DHA Releases Flyer to Educate Servicemembers About Mpox Risk, Protection
In response to the August 2024 upsurge of mpox in the Democratic Republic of Congo and other Africa countries, the Defense Health Agency (DHA) has produced a new flyer: Mpox—What Servicemembers SHOULD KNOW.
Congress Doesn’t Address VA’s PACT Act-Related $12 Billion Shortfall
Before going on recess through mid-November, Congress passed a continuing resolution to keep the federal government funded through Dec. 20, 2024. That resolution, however, did not address the $12 billion shortfall in VHA’s FY 2025 budget,
Continued Issues, Absent Research in Breast Cancer Care for Women Veterans
Breast cancer remains a significant health concern, particularly among women veterans, who face unique challenges within the Veterans Affairs (VA) healthcare system.
Unintended Pregnancy Accounts for Loss of Almost 2.5 Million Military-Readiness Days
Almost 45% percent of pregnancies in the United States are unintended, with an estimated 4.5% of reproductive age women having an unintended pregnancy each year.
Discontinuing SGLT2is, GLP-1 RAs Linked to Negative Outcomes in CKD Patients
Discontinuation of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) is common but is associated with harmful outcomes in adults with chronic kidney disease (CKD), according to a recent study.
Overcoming Barriers to Veteran Participation in Outside-VA Cancer Clinical Trials
While clinical trials are essential for advancing treatment options in oncology and making certain patients receive innovative care, too few cancer patients are referred to them, according to a new study.
Care Access Doesn’t Explain Racial Disparities in Rectal Cancer
Does differential access to care explain racial disparities in treatment and outcomes of rectal cancer? A new study from the Uniformed Services University of the Health Sciences suggested that other factors are likely to be at play.
Pandemic Decreased Already Too Low Lung Cancer Screening Rates
A new study demonstrated how critically the COVID-19 pandemic affected lung cancer screening (LCS).
More Point-of-Care Testing in Military Could Help Curb STI Transmissions
Sexually transmitted infections (STIs) affect an estimated 1 in 5 servicemembers, making early diagnosis and treatment important for controlling their spread among this high-risk population.
New Study Warns About Increased Antibiotic Resistance Against Third-Generation Broad-Spectrum Antibiotics in VA Facilities
VHA facilities across the United States have experienced a concerning rise in antibiotic resistance to third-generation cephalosporins, a class of broad-spectrum antibiotics commonly used to treat the Enterobacterales bacterial species.
Indeterminate Liver Nodules Have a High but Variable Risk of HCC
For more than a decade, the Liver Imaging Reporting and Data System (LI-RADS) has been used to standardize the interpretation and reporting of liver lesions in patients at high risk for hepatocellular carcinoma (HCC).
Homelessness Substantially Increases Risk of Death in Veterans With CKD
U.S. veterans with a history of homelessness had a much greater risk of end-stage kidney disease (ESKD) and death, according to a new study, underscoring the role of housing as a social determinant of health.
Faulty Cell Function in Gulf War Illness Likely Caused By Exposure to Hazardous Agents
Veterans suffering from Gulf War illness (GWI), also known as Gulf War Syndrome (GWS), have faulty cell function that is likely caused by intense exposure to hazardous biological and chemical agents during war service, according to a new study.
